The desmoid syndrome: New aspects in the cause, pathogenesis and treatment of the desmoid tumor

https://doi.org/10.1016/0002-9610(86)90076-0Get rights and content

Abstract

Based on a detailed clinical and laboratory investigation of 89 patients with histologically verified desmoid tumor and the pertinent medical literature, we have reviewed the etiologic factors, clinical characteristics, and results of treatment of this rare disorder. The incidence of the tumor in the Finnish population is low, 2.4 to 4.3 new cases per 106 inhabitants per year. The age distribution profile demonstrated four distinct peak periods: the juvenile period, the fertile period, the middle-age period and the old-age period. The juvenile desmoid tumor is an extraabdominal tumor found in young girls, the fertile variety is an abdominal tumor found in women, the middle age variety is also overwhelmingly abdominal but the sex ratio approaches equality, whereas in the old age group, both abdominal and extraabdominal tumors are equally frequent and the sex ratio is equal. In all male patients, the growth rate was low. A low growth rate was also recorded in young girls. A growth rate of twice that speed was seen in fertile women and four times that speed in the middle age group. In the old age group, a low growth rate, equal to that of male patients, was a rule. The fertile female patients with desmoid tumor had a significant predisposition to estrogen dominance and deviation from progesterone dominance. The direct relationship of the growth rate to the level of endogenous estrogen in the female patients and the demonstration of significant amounts of estradiol but not progesterone receptors in the tumor cytosol further suggest that the growth rate of desmoid tumor is regulated by steroid sex hormones. A significant number of patients with an abdominal desmoid tumor had a history of surgical trauma in the region of subsequent tumor growth. A very high number of the patients demonstrated multiple minor malformations of the bony skeleton. An increased frequency of these malformations was also recorded in the families of the patients and the distribution of the malformations among the family members was compatible with an autosomally dominant pattern of inheritance. After operation, the frequency of recurrence was not statistically different, regardless of whether the tumor was completely removed or not. A combination of operation and radiotherapy did not reduce the frequency of recurrences; in fact, it doubled it.

Taken together, we have introduced the concept of desmoid syndrome as being a desmoid tumor associated with a familial tendency for malformations of the bone, where the initiation of tumor growth is often associated with trauma but regulated by multiple factors, including steroid sex hormones. These characteristics of the desmoid syndrome bear a resemblance to those of Gardner's syndrome, but based on the fact that only 1 of the 75 patients investigated by us had polyposis of the colon, we have suggested that the genes regulating these two disorders are different although operationally related. Analysis of the results of therapy suggest that the basic biologic characteristics of this rare neoplasm have a greater impact on the result than the operation itself; therefore, simple excision during primary operation is recommended.

References (30)

  • MJ Stewart et al.

    Fibroma of the abdominal wall

    Br J Surg

    (1924)
  • E Ruppaner

    Zur Kasuistik der Desmoide der Bauchdecken

    Schweiz Med Wochenschr

    (1936)
  • JE Strode

    Desmoid tumors particularly as related to their surgical removal

    Ann Surg

    (1954)
  • EJ Gardner

    Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts

    Am J Hum Genet

    (1962)
  • AP Stout

    Fibrosarcoma: the malignant tumor of fibroblasts

    Cancer

    (1948)
  • Cited by (0)

    Supported in part by grants from the Finnish Cancer Foundation, Finska Läkaresällskapet, Orion Pharmaceutical Co. Research Foundation, the Oskar Öflunds Foundation and by the Sigrid Juselius Foundation, Helsinki, Finland.

    1

    From the Transplantation Laboratory and Fourth Department of Surgery, University of Helsinki, Helsinki, Finland.

    Dr. Reitamo died on December 4, 1981.

    View full text